Skip to main content

Table 1 Gene family analysis of NTD-targeting infection-enhancing antibodies

From: NIEAs elicited by wild-type SARS-CoV-2 primary infection fail to enhance the infectivity of Omicron variants

mAbs

Heavy chain

Light chain

VH Gene

DH Gene

JH Gene

CDR3 (amino acids)

CDR3 length

% SHM

VL Gene

JL Gene

CDR3 (amino acids)

CDR3 length

% SHM

P5S-1D12

IGHV1-24

IGHD3-3

IGHJ2

ATGSGYSSHWNWYFDL

16

0

IGKV1D-16

IGKJ4

QQYNSYPLT

9

0

DH1052*

IGHV1-69

IGHD2-21

IGHJ4

ATSSGPSRLCGGGSCYHSFDY

21

0

IGKV3-20

IGKJ1

QQYGSSPTWT

10

0

P10S-1A10

IGHV1-69

IGHD2-15

IGHJ6

AREGVVVAAATPLYGMDV

18

0.7

IGKV2D-29

IGKJ2

MQSIHLPYT

9

0.7

8D2*

IGHV3-7

IGHD3-9

IGHJ3

ARDWDYDILTGSWFGAFDI

19

1.4

IGKV1-17

IGKJ4

LQHNSYPLT

9

0

COV2-2490*

IGHV3-7

IGHD3-3

IGHJ4

ARDPYDLYGDYGGTFDY

17

2.7

IGKV1-5

IGKJ4

QQYNSYSLT

9

1.1

P5-1H4

IGHV3-7

IGHD2-15

IGHJ4

ARDLTEAYCSGGGCSEGFDY

20

2.8

IGKV1-5

IGKJ2

QQYHSYPVT

9

1.8

COV2-2369*

IGHV3-30

IGHD5-18

IGHJ4

AKDFGGDNTAMVEYFFDF

18

2.4

IGKV1-5

IGKJ1

QQYNSYSPT

9

0

P5-1B4

IGHV3-33

IGHD4-17

IGHJ4

AKDFGNDYGDIGGNFDY

17

2.4

IGKV1-16

IGKJ4

QQYHSYPLT

9

0.7

P10S-1D9

IGHV3-43

IGHD3-10

IGHJ6

AKDLGSYNYYYGMDV

15

1.7

IGKV3-11

IGKJ4

QQRSNWPLT

9

0

P10S-2E8

IGHV3-48

IGHD3-22

IGHJ5

ARDLFSNYYDSSGYYVFNWFDP

22

0.3

IGKV1-9

IGKJ4

QQLNSYPPT

9

0

P5S-2A8

IGHV4-30

IGHD3-22

IGHJ4

ARGHYSYDNSGTFDY

15

2.1

IGKV1-17

IGKJ4

LQHNTYPLT

9

0.7

P2S-2A5

IGHV4-39

IGHD2-15

IGHJ6

ARDRDSAGSRIMGGMDV

17

0.3

IGKV1-12

IGKJ3

QQANSFPFT

9

0

P5S-1B7

IGHV4-59

IGHD2-15

IGHJ4

AKGDVESCSGGSCYYFDF

18

2.8

IGKV3-20

IGKJ3

QHYGGSPLFT

10

2.5

  1. *Previously published NTD-targeting infection-enhancing antibodies
  2. The program IMGT/V-QUEST was applied to analyze the gene germline, complementarity determining region 3 (CDR3), and somatic hypermutation (SHM). The SHM frequency was calculated from the mutated nucleotides